New strains of norovirus and the mystery of viral gastroenteritis epidemics

CMAJ. Canadian Medical Association Journal

Volumn 185, Issue 16, 2013, Pages 1381-1382

  Lee, Bonita E ^a   Pang, Xiao Li ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CAPSID PROTEIN;

ABDOMINAL CRAMP; AMINO ACID SEQUENCE; BLOOD GROUP LEWIS SYSTEM; CALICIVIRUS; DIARRHEA; EPIDEMIC; GENETIC VARIABILITY; GENOTYPE; HERD IMMUNITY; HUMAN; MALAISE; NAUSEA; NOROVIRUS; NOTE; RNA VIRUS; UNITED STATES; VIRAL GASTROENTERITIS; VIRUS SHEDDING; VIRUS STRAIN; VOMITING;

EID: 84887296036     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.130426     Document Type: Note

References (11)

1. Siebenga JJ, Vennema H, Zheng DP, et al. Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis 2009;200:802-12.
2. Pang XL, Preiksaitis JK, Wong S, et al. Influence of novel norovirus GII.4 variants on gastroenteritis outbreak dynamics in Alberta and the Northern Territories, Canada between 2000 and 2008. PLoS One 2010;5:e11599.
3. van Beek J, Ambert-Balay K, Botteldoorn N, et al. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill 2013; 18:8-9.
4. Hasing ME, Lee BE, Preiksaitis JK, et al. Emergence of a new norovirus GII.4 variant and changes in the historical biennial pattern of norovirus outbreak activity in Alberta, Canada, from 2008 to 2013. J Clin Microbiol 2013;51:2204-11.
5. Bull RA, Eden JS, Rawlinson WD, et al. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog 2010; 6:e1000831.
6. Yang Y, Xia M, Tan M, et al. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J Virol 2010;84:9595-607.
7. Frenck R, Bernstein DI, Xia M, et al. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis 2012;206:1386-93.
8. Lindesmith LC, Costantini V, Swanstrom J, et al. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J Virol 2013;87:2803-13.
9. Desai R, Hembree CD, Handel A, et al. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 2012;55:189-93.
10. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep 2011;60:1-18. Available:www.cdc.gov/mmwr/pdf/rr/rr6003pdf (accessed 2013 Mar. 10).
11. Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011;365:2178-87.